Hunan Warrant Pharmaceutical 华纳药厂
11 significant filings since 30 May 2026: 3 on change of control, 2 on major holder selling and 2 on change of interest, and 3 other kinds. The latest, on 19 Sep 2026: 关于控股股东及一致行动人权益变动触及1%刻度暨控股股东减持股份结果及控股股东合伙人变更持股方式实施完成的公告.
自 30 May 2026 起有 11 份重大公告：change of control 3 份、major holder selling 2 份、change of interest 2 份，另有 3 类。最新一份（19 Sep 2026）：关于控股股东及一致行动人权益变动触及1%刻度暨控股股东减持股份结果及控股股东合伙人变更持股方式实施完成的公告。
Price History 价格走势
1 session 个交易日, Thu 24 Sep 2026 · Live one-minute prices · High 最高 ¥57.96 · Low 最低 ¥56.30 · −2.07% on the previous close of ¥58.08The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
No broker has changed its rating on this company in the reports held.
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 太平洋 | 谭紫媚,张懿 | Buy 买入 | 5 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 1 report. 每行为该券商近十二个月的最新研报；1 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。